Sfrp5 increases glucose-stimulated insulin secretion in the rat pancreatic beta cell line INS-1E

13Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.

Abstract

Previous studies reported that secreted frizzled-related protein-5 (Sfrp5) decreases beta cell proliferation and increases fasting insulin levels, but studies on direct effects of Sfrp5 on insulin secretion and its underlying mechanisms are missing. This study examined effects of Sfrp5 on (i) beta cell viability and proliferation, (ii) basal and glucose-stimulated insulin secretion and (iii) canonical and non-canonical Wnt signalling pathways. We incubated rat INS-1E cells with 0.1, 1 or 5 μg/ml recombinant Sfrp5 for 24h. We measured basal and glucose-stimulated insulin secretion at glucose concentrations of 2.5 and 20 mmol/l. Phosphor-ylated and total protein content as well as mRNA levels of markers of cell proliferation, canonical and non-canonical Wnt signalling pathways were examined using Western blotting and real-time PCR. Differences between treatments were analysed by repeated measurement one-way ANOVA or Friedman’s test followed by correction for multiple testing using the Benjamini-Hochberg procedure. At 5 μg/ml, Sfrp5 reduced mRNA levels of cyclin-B1 by 25% (p<0.05). At 1 and 5 μg/ml, Sfrp5 increased glucose-stimulated insulin secretion by 24% and by 34% (both p<0.05), respectively, but had no impact on basal insulin secretion. Sfrp5 reduced the phosphorylation of the splicing forms p46 and p54 of JNK by 39% (p<0.01) and 49% (p<0.05), respectively. In conclusion, Sfrp5 reduced markers of cell proliferation, but increased in parallel dose-dependently glucose-stimulated insulin secretion in INS-1E cells. This effect is likely mediated by reduced JNK activity, an important component of the non-canonical Wnt signalling pathway.

References Powered by Scopus

Beta cell dysfunction and insulin resistance

698Citations
N/AReaders
Get full text

Beyond Wnt inhibition: New functions of secreted Frizzled-related proteins in development and disease

534Citations
N/AReaders
Get full text

Sfrp5 is an anti-inflammatory adipokine that modulates metabolic dysfunction in obesity

410Citations
N/AReaders
Get full text

Cited by Powered by Scopus

β-Cell Maturation and Identity in Health and Disease

56Citations
N/AReaders
Get full text

The role of anti‐inflammatory adipokines in cardiometabolic disorders: Moving beyond adiponectin

30Citations
N/AReaders
Get full text

Crosstalk Communications Between Islets Cells and Insulin Target Tissue: The Hidden Face of Iceberg

19Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Carstensen-Kirberg, M., Röhrig, K., Niersmann, C., Margriet Ouwens, D., Belgardt, B. F., Roden, M., & Herder, C. (2019). Sfrp5 increases glucose-stimulated insulin secretion in the rat pancreatic beta cell line INS-1E. PLoS ONE, 14(3). https://doi.org/10.1371/journal.pone.0213650

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 7

70%

Researcher 2

20%

Lecturer / Post doc 1

10%

Readers' Discipline

Tooltip

Pharmacology, Toxicology and Pharmaceut... 3

38%

Biochemistry, Genetics and Molecular Bi... 3

38%

Computer Science 1

13%

Neuroscience 1

13%

Article Metrics

Tooltip
Mentions
News Mentions: 1

Save time finding and organizing research with Mendeley

Sign up for free